California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Gold and Asian Stocks Rebound as Market Volatility Eases and Global Sentiment Improves 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
6 simple questions to tell if a ‘finfluencer’ is more flash than cash 
U.S. Stock Futures Slip as Markets Brace for Big Tech Earnings and Key Data 
EU Recovery Fund Faces Bottlenecks Despite Driving Digital and Green Projects 
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated 
Japan’s Agricultural, Forestry and Fishery Exports Hit Record High in 2025 Despite Tariffs 
India Budget 2025 Highlights Manufacturing Push but Falls Short of Market Expectations 
Starbucks denies that its decision to stop selling Chicken, Maple Butter, and Egg Sandwich on June 26, a mere five days after it had been announced as a new permanent menu item, was due to FDA recall or salmonella or listeria contamination.
A Starbucks spokesperson said that the Chicken, Maple Butter, and Egg Sandwich was given a voluntary stop sell and discard order by the company because it didn't live up to the company's high standards for quality.
The quality issue that was identified by Starbucks was simply about taste or based on another issue and would not lead to food-borne illness and any reports linking the stop sale to illness are inaccurate.
The spokesperson added that Starbucks is devoted to providing high-quality products, and anytime a concern about a product or its quality is expressed, we always proceed with extreme caution.
